TNF and COVID-19: Indeed, studies of patients with COVID-19 have reported the increment of inflammatory monocytes and neutrophils, a sharp decrease in lymphocytes, and an inflammatory milieu containing interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF) in severe disease [7, 24, 27–31].